If you’re currently using the FreeStyle Libre 2 or FreeStyle Libre 3 sensor, connect with your healthcare provider to see which new sensor is best for you.
If you’re already using the FreeStyle Libre 3 Plus or FreeStyle Libre 2 Plus sensor, there’s no need to do anything. You’re all set!
In addition to all the great benefits you’ve come to expect—like ease of use1,*2–3, small size, and more—here are some advanced features that set the FreeStyle Libre 3 Plus and FreeStyle Libre 2 Plus sensors apart.
CGM = continuous glucose monitor(ing)
If you have any questions about this change after talking to your healthcare provider, please don’t hesitate to reach out to our Customer Support Team.
Available 7 days a week 8 AM to 8 PM Eastern Time; excluding holidays
Yes. If you are currently using the FreeStyle Libre 2 or FreeStyle Libre 3 sensors, you will need a new prescription for the FreeStyle Libre 3 Plus or FreeStyle Libre 2 Plus sensor. Discuss with your healthcare provider which sensor might be appropriate for you.
Talk to your healthcare provider to decide which sensor makes sense for you. Your current sensor and insulin dosing technology are important to consider.
FreeStyle Libre 3 Plus sensors have the same Medicare coverage as FreeStyle Libre 3 sensors.
FreeStyle Libre 2 Plus sensors have the same Medicare coverage as FreeStyle Libre 2 sensors.
All of these sensors are covered for those managing diabetes with insulin†4,5.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
† Patients must meet eligibility coverage criteria.
References: 4. Data on file. Abbott Diabetes Care, Inc. 5. Local Coverage Determination (LCD) L33822, Glucose Monitors. Accessed Sept 9, 2026. https://www.cms.gov/medicare-coverage-database/view/lcd.aspx?LCDId=33822.
Over 95% of commercial plans cover FreeStyle Libre 3 Plus and FreeStyle Libre 2 Plus sensors4.
Abbott provides this information as a courtesy and does not guarantee payment or coverage.
Reference: 4. Data on file, Abbott Diabetes Care, Inc.
Yes! If you’re commercially insured and asked to pay more than $75 for two sensors, please download our copay card and start saving immediately on your sensors#.
Cost and coverage questions?
844-330-5535 Monday–Friday, 8 AM to 8 PM Eastern Time; excluding holidays
Abbott provides this information as a courtesy and does not guarantee payment or coverage.
# Benefits for FreeStyle Libre CGM systems apply to FreeStyle Libre CGM systems sensors and readers. Void where prohibited by law. Abbott may modify, rescind, or revoke these benefits at any time without notice. Offer available to commercially insured and uninsured patients only. These benefits are not available to beneficiaries of Medicare, Medicaid or other federal or state healthcare programs. For Massachusetts residents, only those patients responsible for the full cost of the product may be eligible to receive these benefits. These benefits are only available at participating pharmacies, which are subject to change without notice. The actual amount a patient pays may vary.
The FreeStyle Libre 3 Plus and FreeStyle Libre 2 Plus sensors are widely available through retail pharmacies, durable medical equipment (DME) suppliers, mail order companies, and government pharmacies with a valid prescription.
Yes. You can continue using the existing FreeStyle Libre apps‡ or FreeStyle Libre 3 reader§ with the FreeStyle Libre 3 Plus sensor.
‡ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
§ The FreeStyle Libre systems apps and the FreeStyle Libre systems readers have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
Yes. You can continue using the existing FreeStyle Libre apps‡ or FreeStyle Libre 2 reader§ with the FreeStyle Libre 2 Plus sensor.
‡ The FreeStyle Libre systems apps are only compatible with certain mobile devices and operating systems. Please check the Support section of our website for more information about device compatibility before using the apps. Use of the FreeStyle Libre systems apps may require registration with LibreView.
§ The FreeStyle Libre systems apps and the FreeStyle Libre systems readers have similar but not identical features. Fingersticks are required for treatment decisions when you see Check Blood Glucose symbol and when your glucose alarms and readings from the system do not match symptoms or expectations.
Yes. We will gladly continue providing ongoing support for the FreeStyle Libre 2 and FreeStyle Libre 3 sensors, even after discontinuation.
Talk to your healthcare provider today.
This simple discussion guide can help you get the conversation started.
Which FreeStyle Libre sensor is right for you?
Compare CGMs to see which features could benefit you.
The FreeStyle Libre 3 system and FreeStyle Libre 2 system are indicated for use in people with diabetes age 4 and older.
The Freestyle Libre 2 Plus sensor and Freestyle Libre 3 Plus sensor are indicated for use in people with diabetes age 2 and older.
Medicare and other payor criteria may apply. Abbott provides this information as a courtesy and does not guarantee payment or coverage.
* Study was performed with the outside US version of the FreeStyle Libre 14 day system. Data is applicable to FreeStyle Libre 2 and FreeStyle Libre 3 systems, as feature sets are similar.
References: 1. Alva, Shridhara, et al. “Accuracy of the Third Generation of a 14-Day Continuous Glucose Monitoring System.” Diabetes Therapy 14, no. 4 (2023): 767–776. https://doi.org/10.1007/s13300-023-01385-6. 2. Haak, Thomas, et al. “Flash Glucose-Sensing Technology as a Replacement for Blood Glucose Monitoring for the Management of Insulin-Treated Type 2 Diabetes: a Multicentre, Open-Label Randomised Controlled Trial.” Diabetes Therapy 8, no. 1 (2017): 55–73. https://doi.org/10.1007/s13300-016-0223-6. 3. Campbell, Fiona, et al. “Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study.” Pediatric Diabetes 19, no. 7 (2018): 1294–1301. https://doi.org/10.1111/pedi.12735.
The "Yes" link below will take you out of the Abbott Laboratories family of websites. Links which take you out of Abbott Laboratories worldwide web sites are not under the control of Abbott Laboratories, and Abbott Laboratories is not responsible for the contents of any such site or any further links from such site. Abbott Laboratories is providing these links to you only as a convenience, and the inclusion of any link does not imply endorsement of the linked site by Abbott Laboratories.
Do you wish to leave this site?
